IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study investigates whether intravenous (IV) iron [Feraheme (ferumoxytol) injection)] is
a better treatment than oral iron pills (ferrous sulfate) for correcting anemia in women who
have heavy menstrual bleeding and anemia. Investigators will study whether women's blood
counts respond better, respond more quickly, and if women prefer the IV treatment or the oral
treatment. Women who have heavy menstrual bleeding and anemia will be randomly assigned to
receive treatment with either oral iron pills or IV iron infusions. Investigators will then
check whether and how quickly the anemia improves, and survey participants on how satisfied
they were with the treatment.